Bisphosphonate Use and Periprosthetic Fractures

J Arthroplasty. 2024 Jan;39(1):e1-e2. doi: 10.1016/j.arth.2023.09.015.

Authors

Assil-Ramin Alimy¹, Frank Timo Beil¹, Michael Amling², Tim Rolvien¹

Affiliations

¹ Division of Orthopaedics, Department of Trauma and Orthopaedic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Department of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

PMID: 38042571
DOI: 10.1016/j.arth.2023.09.015

No abstract available

Publication types

Letter

MeSH terms

Arthroplasty, Replacement, Hip*
Bone Density Conservation Agents* / adverse effects
Diphosphonates / adverse effects
Femoral Fractures* / surgery
Humans
Periprosthetic Fractures* / etiology
Periprosthetic Fractures* / surgery
Reoperation
Retrospective Studies

Substances

Diphosphonates
Bone Density Conservation Agents